Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2006-11-3
pubmed:abstractText
Janus kinase 3 (JAK3) mediates signal transduction from cytokine receptors using the common gamma chain. The rationally designed inhibitor of JAK3, CP-690,550, prevents acute allograft rejection in rodents and in nonhuman primates. Here we investigated the ability of CP-690,550, to prevent allograft vasculopathy in a rodent model of aorta transplantation. Aortas from AxC Irish (RT1(a)) or Lewis (RT1(l)) rats were heterotopically transplanted into the infra-renal aorta of Lewis recipients and harvested at 28 or 56 days. Treated recipients received CP-690,550 by osmotic pumps (mean drug exposure of 110 +/- 38 ng/ml). Significant intimal hyperplasia was demonstrated in untreated allografts when compared with isografts at 28 days (2.08 +/- 0.85% vs. 0.43 +/- 0.2% luminal obliteration, respectively, P = 0.001) and 56 days (5.3 +/- 2.4% vs. 0.38 +/- 0.3%, P = 0.002). Treatment caused a 51% reduction in intimal hyperplasia at day 56. CP-690,550-treated animals also had a significant reduction of donor-specific IgG production and of the gene expression for suppressor of cytokine signaling-3 and with unchanged levels of expression of RANTES, IP-10 and transforming growth factor-beta1. These results are the first to show that JAK3 blockade by CP-690,550 effectively prevents allograft vasculopathy in this rat model of aorta transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0934-0874
pubmed:author
pubmed:issnType
Print
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1014-21
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17081232-Animals, pubmed-meshheading:17081232-Aorta, pubmed-meshheading:17081232-Arteriosclerosis, pubmed-meshheading:17081232-Chemokine CCL5, pubmed-meshheading:17081232-Hyperplasia, pubmed-meshheading:17081232-Interferon-gamma, pubmed-meshheading:17081232-Janus Kinase 3, pubmed-meshheading:17081232-Killer Cells, Natural, pubmed-meshheading:17081232-Male, pubmed-meshheading:17081232-Protein Kinase Inhibitors, pubmed-meshheading:17081232-Pyrimidines, pubmed-meshheading:17081232-Pyrroles, pubmed-meshheading:17081232-Rats, pubmed-meshheading:17081232-Rats, Inbred ACI, pubmed-meshheading:17081232-Rats, Inbred Lew, pubmed-meshheading:17081232-Suppressor of Cytokine Signaling Proteins, pubmed-meshheading:17081232-Transplantation, Homologous, pubmed-meshheading:17081232-Tunica Intima
pubmed:year
2006
pubmed:articleTitle
Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathy.
pubmed:affiliation
Transplantation Immunology Laboratory, Department of Cardiothoracic Surgery, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, CA 94305-5407, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't